Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.
about
Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)Role of alpha 1- and beta 3-adrenoceptors in the modulation by SR59230A of the effects of MDMA on body temperature in the mouseInteractions between 3,4-methylenedioxymethamphetamine and sigma1 receptorsPsychedelics and Immunomodulation: Novel Approaches and Therapeutic OpportunitiesEffects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis)The effects of ecstasy on neurotransmitter systems: a review on the findings of molecular imaging studiesComparative neuropharmacology of three psychostimulant cathinone derivatives: butylone, mephedrone and methyloneVascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized ratEffect of ambient temperature on the thermoregulatory and locomotor stimulant effects of 4-methylmethcathinone in Wistar and Sprague-Dawley ratsDuloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory studyNon-Serotonergic Neurotoxicity by MDMA (Ecstasy) in Neurons Derived from Mouse P19 Embryonal Carcinoma CellsDevelopmental effects of 3,4-methylenedioxymethamphetamine: a reviewThe role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivativesEcstasy (3,4-methylenedioxymethamphetamine) limits murine gammaherpesvirus-68 induced monokine expression.Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys.Contributions of serotonin in addiction vulnerability.Role of alpha2A-adrenoceptors in the effects of MDMA on body temperature in the mouseAcute psychological and neurophysiological effects of MDMA in humans.Monoamine reuptake inhibitors in Parkinson's disease.Pharmacogenetics of monoamine transporters.Prenatal exposure to MDMA alters noradrenergic neurodevelopment in the rat.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Analysis of transcriptional responses in the mouse dorsal striatum following acute 3,4-methylenedioxymethamphetamine (ecstasy): identification of extracellular signal-regulated kinase-controlled genes.Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans.Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys.Expression of neuronal trace amine-associated receptor (Taar) mRNAs in leukocytes.Ecstasy (MDMA) Alters Cardiac Gene Expression and DNA Methylation: Implications for Circadian Rhythm Dysfunction in the Heart.The molecular mechanism of "ecstasy" [3,4-methylenedioxy-methamphetamine (MDMA)]: serotonin transporters are targets for MDMA-induced serotonin release.3,4-Methylenedioxy-N-methamphetamine (ecstasy) promotes the survival of fetal dopamine neurons in culture.MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen PharmacologyEffects of MDMA on body temperature in humansEcstasy produces left ventricular dysfunction and oxidative stress in rats.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.Neuropathology of substance use disorders.Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA).The effects of MDMA on socio-emotional processing: Does MDMA differ from other stimulants?MDMA-induced impairment in primates: antagonism by a selective norepinephrine or serotonin, but not by a dopamine/norepinephrine transport inhibitor.Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.Role of alpha1-adrenoceptor subtypes in the effects of methylenedioxy methamphetamine (MDMA) on body temperature in the mouse3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): pharmacology and toxicology in animals and humans.
P2860
Q22251113-90348C8E-4F8F-48EF-BD8C-1CA4108FE577Q24656536-99609662-280E-4C75-9C70-96E668A9A276Q24683869-DE67EEBD-0F03-46C9-BD41-2D2922C68DFCQ26799997-08341108-3B90-45EC-8A85-8CCC44A2752CQ27329826-B16E8114-8B6D-4D11-B74C-D238F4C2FA48Q28069364-77D2A396-4D8B-444B-BF53-7788B57160EBQ28264655-6EE8AFDB-CA14-48B2-A273-9179EC767FB5Q28365866-A31E0F81-608B-4277-8420-466B105CB187Q28483306-19CC151B-FCB3-40F1-B832-FA5D371718A3Q28483370-8A6D3573-527A-42AD-B6E2-91D749AB7E24Q28553620-86F6DF23-575D-45BA-AA8F-372F3C80410BQ33923930-FB477546-3ED7-4815-B803-7735722BA0F6Q34112933-8E9658B2-D80C-4389-803F-90909FEC2388Q34767737-B7F90D3F-4F65-41B3-A323-A55C91505AE4Q35017128-1708E84F-220C-4094-B028-3B90FB4AF59CQ35032325-A857484C-5C28-41DA-B612-A74C0DF60D66Q35049138-5885E781-DACB-4A71-A25E-3D5E6754AA9BQ35105559-18F679A6-0763-4B2F-ABFD-4A56723D8041Q35165280-3A53E748-AB27-467D-B5F3-9D4250D092BAQ35207551-F00B6DFE-05C0-486F-A5BB-E33F27A93C69Q35713639-5532849E-43BB-4CFD-AA7C-A323EBC84B59Q35754068-3CB9A34B-5B17-4F00-8C44-4B2EB4C22D10Q36012516-20101C7E-5A43-43D5-97B3-53333252F042Q36252777-A5143E1B-E459-4F44-88C7-38C03D3B1021Q36312733-F7B3BE9E-28CB-4ADB-B18D-CA9DA2A5A0DCQ36357170-FF2031BE-47CB-4984-B802-D79539B37B29Q36515912-915174B8-3297-4E29-BBDA-B9D8ABA4C8BFQ36862351-8B93AAF6-C5BE-4975-AB6B-4BDF339422F1Q36948238-C87E3D8A-AF60-468C-8083-0C0CA97BCAACQ37149027-ED21FC46-DB67-4D90-B94E-5C91B20E17C8Q37226598-4D7B35A1-CB02-4359-9603-1A1EF4E8F344Q37318873-0D8495A7-27D2-46B6-9D6E-3D043AB2DC3EQ38048826-DCCAC418-47A5-43C2-9341-F47DD279F1A2Q38167646-D8542F96-2A3B-4DD1-8796-C1B1AE9D8586Q38652284-BFC593A8-96E5-4A28-85BA-36E81BB0D3C2Q38937390-C4D6B884-4C0B-4724-9EED-BCA4BDC71DF5Q40007746-450D811A-1576-438C-9B92-49AAA22F1665Q40309889-A45FD532-BDC3-4BDB-A80D-3E05BEA57B26Q40433735-A00F5011-9DEB-4DFD-905E-75217EE38C8BQ40624643-37CE6243-0225-49CA-A123-5ABD7C568F1A
P2860
Pharmacologic profile of MDMA (3,4-methylenedioxymethamphetamine) at various brain recognition sites.
description
1988 nî lūn-bûn
@nan
1988 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@ast
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@en
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@nl
type
label
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@ast
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@en
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@nl
prefLabel
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@ast
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@en
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@nl
P2093
P1476
Pharmacologic profile of MDMA ...... rious brain recognition sites.
@en
P2093
Battaglia G
De Souza EB
Kulsakdinun C
P304
P356
10.1016/0014-2999(88)90056-8
P407
P577
1988-04-01T00:00:00Z